The impact of developmental haemostasis on the pharmacokinetics and pharmacodynamics of heparin in children. [ 2007 - 2009 ]

Research Grant

Researchers: Prof Paul Monagle (Principal investigator) ,  A/Pr Noel Cranswick ,  A/Pr Vera Ignjatovic

Brief description Unfractionated Heparin (UFH) is the most commonly used anticoagulant (blood thinning drug) in children. Despite this, the clinical evidence, in terms of reported treatment failures and bleeding complications, suggests the drug is used suboptimally in children compared to adults.This likely relfects the lack of specific studies of UFH in children. This study will, for the first time, define the pharmacokinetics-dynamics of UFH in children, allowing age-specific protocols to be developed. Pharmacological modelling of this data will likely have implications for the use of other anticoagulants in children.

Funding Amount $AUD 283,676.77

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant